Scotland · NHS Scotland MSAN
Co-codamol 30mg/500mg tablets
MSAN(2026)3 · Level 3 · issued 14 Jan 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Co-codamol 30mg/500mg tablets will be in limited supply from early February until early June | Limited supply | early June |
| 2. Paracetamol 500mg tablets remain available and can support a full uplift in demand. | Available | — |
| 3. Codeine 30mg tablets remain available and can support a partial uplift in demand. | Available — partial uplift only | — |
| 4. Co-codamol 30mg/500mg capsules remain available and can support a partial uplift in demand | Available — partial uplift only | — |
| 5. Co-codamol 30mg/500mg effervescent tablets remain available but cannot support an uplift in | Available — cannot support uplift | — |
| 6. Other strengths and forms of co-codamol remain available but cannot support an uplift in | Available — cannot support uplift | — |
| 7. Co-dydramol 30mg/500mg and 20mg/500mg tablets remain available but cannot support an | Available — cannot support uplift | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.